Skip to main content

ACHC Acadia Healthcare Company, Inc.

Healthcare

37.78 USD Close 11/13
Since 2024-12-16 -6.7%

Close 11/13

Open
38.00
High
38.12
Low
36.88
Prev close
37.81
Volume
2.23M
Amplitude
3.28%
P/B
1.7
Revenue YoY (TTM)
+4.5%
52W 11.43 39.70
FinLab Studio

From Acadia Healthcare Company, Inc. to every stock like it

AI finds several complementary traits of Acadia Healthcare Company, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Acadia Healthcare Company, Inc.

Is Acadia Healthcare Company, Inc. a buy? Fundamentals and valuation first

As of 2026-11-13

Valuation: Fair, Momentum: Strong, Risk / liquidity: Good; Quality: Weak, Growth: Weak.

Valuation Fair Free-cash-flow yield is Good, but Price / book is Pricey.
TTM P/E -3.0 N/A
Price / book 1.7 55th percentile · Pricey
Free-cash-flow yield (%) 2.6 57th percentile · Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Weak Operating margin, TTM is Good, but ROE, TTM is Lagging.
ROE, TTM (%) -55.8 17th percentile · Lagging
Operating margin, TTM (%) 9.8 55th percentile · Good
FCF margin, TTM (%) 2.7 46th percentile · Average
Quality Factor Investing: A US Quality Value Backtest
Growth Weak Revenue growth, TTM YoY is Average; Diluted EPS growth, TTM YoY is Lagging.
Revenue growth, TTM YoY (%) 4.5 46th percentile · Average
Diluted EPS growth, TTM YoY (%) -1,166.2 3th percentile · Lagging
Momentum Strong All 2 indicators are Top.
60-day return (%) 40.1 98th percentile · Top
240-day return (%) 124.4 98th percentile · Top
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Good 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 79,538,459.0 85th percentile · Top
60-day annualized volatility (%) 46.0 48th percentile · Good
Factor Investing Explained: 10 Classic Factors in US Stocks

Acadia Healthcare Company, Inc. (ACHC) today

3 quant signals active · As of 2026-11-13

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

Acadia Healthcare Company, Inc. (ACHC) peers and tracking

Watchlist

This page refreshes daily after the close. Add Acadia Healthcare Company, Inc. to your watchlist to track signal changes on your next visit.

Acadia Healthcare Company, Inc. (ACHC) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

16 historical occurrences (since 2020-02-20)

Average forward return after 52-week adjusted-price high

20-day: Win 40.0%, Sample 15, Median -3.6%, Excess -3.1%, Beat mkt rate 40.0%

60-day: Win 40.0%, Sample 15, Median -1.1%, Excess -1.9%, Beat mkt rate 46.7%

120-day: Win 42.9%, Sample 14, Median -2.5%, Excess -4.7%, Beat mkt rate 21.4%

120 days after: historical avg +1.7%

20-day -4.0%
60-day -0.0%
120-day +1.7%
20-day
60-day
120-day
Win
40.0%
40.0%
42.9%
Sample
15
15
14
Median
-3.6%
-1.1%
-2.5%
Excess
-3.1%
-1.9%
-4.7%
Beat mkt rate
40.0%
46.7%
21.4%

Over 14 occurrences, 120-day forward avg gained 1.7%, lagged the market by 4.7 pts; win rate 42.9%.

Top-quintile 6-month momentum

Active · now 89.6%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

Momentum Trading Strategy: A 12-1 Momentum Backtest
13 historical occurrences (since 2017-06-09)

Average forward return after Top-quintile 6-month momentum

20-day: Win 58.3%, Sample 12, Median +2.8%, Excess -2.0%, Beat mkt rate 66.7%

60-day: Win 66.7%, Sample 12, Median +2.7%, Excess +4.8%, Beat mkt rate 58.3%

120-day: Win 50.0%, Sample 12, Median -5.2%, Excess +2.9%, Beat mkt rate 41.7%

120 days after: historical avg +7.4%

20-day -3.6%
60-day +7.2%
120-day +7.4%
20-day
60-day
120-day
Win
58.3%
66.7%
50.0%
Sample
12
12
12
Median
+2.8%
+2.7%
-5.2%
Excess
-2.0%
+4.8%
+2.9%
Beat mkt rate
66.7%
58.3%
41.7%

Over 12 occurrences, 120-day forward avg gained 7.4%, beat the market by 2.9 pts; win rate 50.0%.

EPS surprise beat

Active · now 29.7%

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

PEAD: Post-Earnings Announcement Drift Backtest
23 historical occurrences (since 2015-08-04)

Average forward return after EPS surprise beat

20-day: Win 60.0%, Sample 20, Median +1.2%, Excess +0.7%, Beat mkt rate 55.0%

60-day: Win 60.0%, Sample 20, Median +1.3%, Excess +0.7%, Beat mkt rate 45.0%

120-day: Win 68.4%, Sample 19, Median +7.3%, Excess +5.9%, Beat mkt rate 63.2%

120 days after: historical avg +15.3%

20-day +2.5%
60-day +5.0%
120-day +15.3%
20-day
60-day
120-day
Win
60.0%
60.0%
68.4%
Sample
20
20
19
Median
+1.2%
+1.3%
+7.3%
Excess
+0.7%
+0.7%
+5.9%
Beat mkt rate
55.0%
45.0%
63.2%

Over 19 occurrences, 120-day forward avg gained 15.3%, beat the market by 5.9 pts; win rate 68.4%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 101,149 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.29%, a 58.4% positive-return rate, and +2.96 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

6 times historically; 60-day forward avg +6.0%, win rate 66.7%, beating the market by +5.5 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.